Dupilumab-induced ocular surface disease: A systematic review

J Am Acad Dermatol. 2022 Feb;86(2):486-487. doi: 10.1016/j.jaad.2021.09.029. Epub 2021 Sep 21.

Authors

Tahel Fachler¹, Rony Shreberk-Hassidim¹, Vered Molho-Pessach²

Affiliations

¹ Department of Dermatology, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
² Department of Dermatology, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel. Electronic address: rverem@hadassah.org.il.

PMID: 34560194
DOI: 10.1016/j.jaad.2021.09.029

No abstract available

Keywords: atopic dermatitis; conjunctivitis; dupilumab; ocular surface disease.

Publication types

Letter
Systematic Review

MeSH terms

Antibodies, Monoclonal, Humanized* / adverse effects
Eye Diseases*
Humans

Substances

Antibodies, Monoclonal, Humanized
dupilumab